MATHEW NGUYEN: Open Payments
NPI 1083650261 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101,448 in 196 payments from 7 companies in 2025. Trend: 2023 $2,326 · 2024 $2,193 · 2025 $101,448
Speaker / faculty: $76,500Travel & lodging: $20,803Food & beverage: $4,145
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 184 | $100,838 |
| Teva Pharmaceuticals USA, Inc. | 3 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $154 |
| Neurocrine BioSciences, Inc. | 2 | $153 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: INVEGA SUSTENNA, INVEGA, CAPLYTA, INGREZZA, UZEDY, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
